Philip J. Gotwals's most recent trade in OmniAb Inc was a trade of 40,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| OmniAb Inc | Philip J. Gotwals | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| OmniAb Inc | Philip J. Gotwals | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 20,000 | 60,000 | - | - | Restricted Stock Units | |
| OmniAb Inc | Philip J. Gotwals | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2025 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| OmniAb Inc | Philip J. Gotwals | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2025 | 40,000 | 40,000 | - | - | Restricted Stock Units | |
| Capricor Therapeutics Inc | Philip J. Gotwals | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 11,940 | 11,940 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Philip J. Gotwals | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 5,750 | 5,750 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Philip J. Gotwals | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 2,160 | 2,160 | - | - | Stock Option (Right to Buy) |